With almost three decades of experience in the Swedish life science industry, Jan Hellqvist, general manager of KLIFO in Sweden, explains why the country has seen the number of clinical studies from small and medium size companies skyrocket in recent years. Moreover, he discusses the possibilities of opening KLIFO’s affiliate and his strategy to position the Danish CRO among the best in the region.
KLIFO understands that small companies need knowledge and senior advice on the best route to market for their specific drugs.
